Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2019-03-14 Major Shareholding Noti…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and explicitly details an 'acquisition or disposal of voting rights' by 'CASTLEFIELD FUND PARTNERS LIMITED' concerning shares in 'BIOVENTIX'. Section 7 shows the resulting holding percentage (15.36%) and the date the threshold was crossed (7TH MARCH 2019). This structure perfectly matches the requirements for notifying changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category.
2019-03-14 English
Bioventix Plc - Issue of Equity
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces the 'Issue of Equity' resulting from the exercise of employee stock options, leading to the admission of 1,000 new ordinary shares to trading on AIM. This action directly changes the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA) better than 'Transaction in Own Shares' (POS), which usually refers to buybacks or direct treasury transactions, although both are related to capital. Since the core event is the issuance of new shares and the resulting change in total voting rights, SHA is the most precise fit.
2019-01-29 English
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory template used in the UK to report when a shareholder's interest in a company crosses a specific threshold. This document explicitly identifies the issuer (Bioventix Plc) and the entity subject to the notification (Castlefield Fund Partners Limited), detailing the percentage of voting rights held. This fits the definition of a 'Major Shareholding Notification'.
2019-01-17 English
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' for Bioventix Plc. It details a change in shareholding by Castlefield Fund Partners Limited, crossing a specific threshold. This is a classic regulatory disclosure document used to notify the market and the FCA of significant changes in share ownership, which falls under the 'Major Shareholding Notification' category.
2019-01-17 English
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and explicitly details an 'acquisition or disposal of voting rights' by 'CASTLEFIELD FUND PARTNERS LIMITED' concerning shares in 'BIOVENTIX'. This form (TR-1) is the standard regulatory notification required under the EU Transparency Directive (DTR 5) when a shareholder's holding crosses a major threshold (e.g., 3%, 5%, 10%, 15%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. The filing type code matching this description is 'MRQ' (Major Shareholding Notification).
2019-01-17 English
Bioventix Plc - Result of AGM
AGM Information Classification · 99% confidence The document explicitly states in the title and body: "# Bioventix Plc - Result of AGM" and "Bioventix plc announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly passed." This directly indicates the content is related to the outcome of the Annual General Meeting. This aligns perfectly with the definition for AGM Information (AGM-R). The document is short and reports the result, not a presentation or detailed voting breakdown, making AGM-R the most appropriate classification over DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually for detailed results.
2018-12-06 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.